Carcinogenic ability quantification of human papilloma virus subtypes in eastern China
- PMID:26112600
- DOI: 10.1002/jmv.24280
Carcinogenic ability quantification of human papilloma virus subtypes in eastern China
Abstract
Human papilloma virus (HPV) infection is a precursor of cervical cancer. This study aimed to introduce a method to quantify the risk of cervical cancer resulting from infection by different HPV subtypes, to help guide patient treatment. Nucleic acid molecule flow-through hybridization and gene chip technology were used to test 6,510 non-cervical cancer healthy volunteers (≤CIN-I) and 204 cervical cancer patients (≥CIN-III) from Dongying City for 21 HPV subtypes (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 6, 11, 42, 43, 44, 53, 66 and CP8304) in exfoliated cervical cells. The positive proportion of HPV subtypes was calculated, excluding or including patients with multiple subtype infections. The lower (L) and upper (H) limits of the carcinogenic risk score range were calculated, respectively. The values of carcinogenic index ± uncertainty in the carcinogenic ability (CI ± U) were also calculated. CI = (H + L)/2 represents the carcinogenic risk of the different subtypes, and U =(H - L)/2 represents the probability of each subtype being present in multiple infections. Infection rates were 15.87 and 96.57%, and HPV subtypes with high infection rates were HPV-16, 52, 58, 33, 18, and 31 and HPV-16, 31, 58, 18, 68, and 33 in the non-cervical cancer and cervical cancer groups, respectively. HPV subtypes with high risk of cervical cancer were HPV-31 (3.71 ± 0.68), 51 (2.65 ± 0.44), 18 (2.03 ± 0.43), 68 (1.76 ± 0.40), 58 (1.68 ± 0.49), and 16 (1.39 ± 0.33). We have provided a quantitative method for expressing HPV subtype carcinogenic risk.
Keywords: papillomavirus infections; risk; uterine cervical neoplasms.
© 2015 Wiley Periodicals, Inc.
Similar articles
- [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].Wang WP, An JS, Yao HW, Li N, Zhang YY, Ge L, Song Y, Wang MJ, Yuan GW, Sun YC, Huang MN, Wu LY.Wang WP, et al.Zhonghua Fu Chan Ke Za Zhi. 2019 May 25;54(5):293-300. doi: 10.3760/cma.j.issn.0529-567x.2019.05.002.Zhonghua Fu Chan Ke Za Zhi. 2019.PMID:31154709Chinese.
- Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China.Liu HY, Zhou SL, Ku JW, Zhang DY, Li B, Han XN, Fan ZM, Cui JL, Lin HL, Guo ET, Chen X, Yuan Y, Han JJ, Zhang W, Zhang LQ, Zhou FY, Liao SX, Hong JY, Wang LD.Liu HY, et al.Arch Virol. 2014 Jun;159(6):1393-401. doi: 10.1007/s00705-013-1943-9. Epub 2014 Jan 3.Arch Virol. 2014.PMID:24385156
- Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women.Zhang R, Shi TY, Ren Y, Lu H, Wei ZH, Hou WJ, Zhang M, Xu C.Zhang R, et al.J Clin Virol. 2013 Sep;58(1):144-8. doi: 10.1016/j.jcv.2013.06.012. Epub 2013 Jul 9.J Clin Virol. 2013.PMID:23849649
- Clinical significance of human papilloma virus infection in the cervical lesions.Li S, Meng YH, Ting H, Shen J, Ma D.Li S, et al.Front Med China. 2010 Sep;4(3):264-70. doi: 10.1007/s11684-010-0094-6. Epub 2010 Jul 16.Front Med China. 2010.PMID:21191829Review.
- Human papilloma virus molecular profile and mechanisms of cancerogenesis: a review.Deligeoroglou E, Christopoulos P, Aravantinos L, Papadias K.Deligeoroglou E, et al.Eur J Gynaecol Oncol. 2009;30(2):128-32.Eur J Gynaecol Oncol. 2009.PMID:19480239Review.
Cited by
- Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.Xu HH, Wang K, Feng XJ, Dong SS, Lin A, Zheng LZ, Yan WH.Xu HH, et al.Oncotarget. 2018 Jan 11;9(20):15386-15397. doi: 10.18632/oncotarget.24169. eCollection 2018 Mar 16.Oncotarget. 2018.PMID:29632652Free PMC article.
- Anal HPV/HIV co-infection among Men Who Have Sex with Men: a cross-sectional survey from three cities in China.Li X, Li M, Yang Y, Zhong X, Feng B, Xin H, Li Z, Jin Q, Gao L.Li X, et al.Sci Rep. 2016 Feb 19;6:21368. doi: 10.1038/srep21368.Sci Rep. 2016.PMID:26892938Free PMC article.
- HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, Wang R, Wang J, Qi D.Jiang L, et al.PLoS One. 2019 Jan 17;14(1):e0210311. doi: 10.1371/journal.pone.0210311. eCollection 2019.PLoS One. 2019.PMID:30653566Free PMC article.
- Age-specific prevalence and genotype distribution of human papillomavirus in women from Northwest China.Lin X, Chen L, Zheng Y, Yan F, Li J, Zhang J, Yang H.Lin X, et al.Cancer Med. 2022 Nov;11(22):4366-4373. doi: 10.1002/cam4.4732. Epub 2022 Apr 1.Cancer Med. 2022.PMID:35365956Free PMC article.
- Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014-2018.Ma L, Lei J, Ma L, Cong X, Wang N, Yang H, Liu Q, Yu Y, Cao Y.Ma L, et al.BMC Infect Dis. 2019 Jul 29;19(1):670. doi: 10.1186/s12879-019-4313-8.BMC Infect Dis. 2019.PMID:31357941Free PMC article.
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical